Investor Relations

4th QUARTER/Full Year 2023


Evonik published its quarterly report Q4/FY 2023 on March 4, 2024. 

You can access further information here.

  • Q4 adj. EBITDA of €312 m to finish the year at €1,656 m and within outlook range (€1.6 to 1.8 bn) despite around -€50 m exceptional headwinds in Q4
  • Update on reorganization program “Evonik Tailor Made”: Total savings of €400 m targeted by end of 2026
  • FCF of €801 m stable yoy despite significant earnings decline, covering attractive & stable dividend proposal of €1.17
  • FY 2024 adj. EBITDA outlook of €1.7 to 2.0 bn: Earnings growth enabled by cost savings and Animal Nutrition; Q1 already expected above prior-year level

Reporting 4th Quarter/FY 2023

Link / PDF
Analyst & Investor Factsheet
Presentation Conference Call

Detailed overview of key financial data (Evonik Financials) - PDF

Detailed overview of key financial data (Evonik Financials) - Excel

Detailed overview of ESG data - PDF

Detailed overview of ESG data - Excel

Financial Report 2023

Sustainability Report 2023

Investor Relations News Q4/FY 2023

Analysts' consensus* (Vara Research)

Webcast Conference Call Q4/FY 2023
(March 4, 2023, 2.00 p.m. CET)

* The consensus is not controlled, changed or censored by Evonik Industries AG. Evonik Industries AG assumes no liability for the accuracy and completeness of these estimates and undertakes no obligation to update or revise such estimates and consensus data, even if they differ from Evonik Industries AG’s own forecasts or expectations. Evonik Industries AG is neither involved in the collection of the data, nor in the preparation of the consensus. This is done independently by Vara Research.